Marker Therapeutics, Inc. financial statements
Marker Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 3.55M | 10-K |
| Net income | −USD 12.16M | 10-K |
| Cash and equivalents | USD 16.07M | 10-Q |
Marker Therapeutics, Inc. financials on 6ix · Marker Therapeutics, Inc. on 6ix